Anne L. Carrington

3.5k total citations · 1 hit paper
35 papers, 2.5k citations indexed

About

Anne L. Carrington is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Neurology. According to data from OpenAlex, Anne L. Carrington has authored 35 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Physiology and 10 papers in Neurology. Recurrent topics in Anne L. Carrington's work include Diabetic Foot Ulcer Assessment and Management (13 papers), Pain Mechanisms and Treatments (13 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Anne L. Carrington is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (13 papers), Pain Mechanisms and Treatments (13 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Anne L. Carrington collaborates with scholars based in United Kingdom, Sweden and France. Anne L. Carrington's co-authors include Andrew J.M. Boulton, Caroline A. Abbott, David R. Tomlinson, Loretta Vileikytė, E. R. E. Van Ross, John R. Griffiths, Nicky Jackson, Elizabeth Stevens, Kristen E. Johnson and Sarah C. Bath and has published in prestigious journals such as The Lancet, Diabetes Care and Diabetologia.

In The Last Decade

Anne L. Carrington

35 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort

2002 752 citations Caroline A. Abbott, Anne L. Carrington et al. Diabetic Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne L. Carrington United Kingdom	20	1.5k	822	752	554	531	35	2.5k
E. R. E. Van Ross United Kingdom	5	820 0.5×	462 0.6×	616 0.8×	310 0.6×	482 0.9×	5	1.5k
A Vinik United States	20	841 0.6×	127 0.2×	1.0k 1.4×	46 0.1×	781 1.5×	59	2.8k
Stephan Praet Netherlands	24	471 0.3×	143 0.2×	652 0.9×	56 0.1×	65 0.1×	48	1.7k
Henri K. Parson United States	19	482 0.3×	148 0.2×	631 0.8×	25 0.0×	415 0.8×	36	1.6k
Niels Ejskjær Denmark	26	570 0.4×	55 0.1×	811 1.1×	63 0.1×	377 0.7×	107	2.0k
Dinesh Selvarajah United Kingdom	27	757 0.5×	115 0.1×	2.0k 2.7×	31 0.1×	1.4k 2.7×	57	3.3k
Christos Manes Greece	11	657 0.4×	69 0.1×	702 0.9×	35 0.1×	494 0.9×	15	1.5k
Hsinlin T. Cheng United States	20	464 0.3×	132 0.2×	1.2k 1.6×	20 0.0×	582 1.1×	38	2.4k
Norio Hotta Japan	27	427 0.3×	112 0.1×	637 0.8×	28 0.1×	173 0.3×	122	2.3k
J. Robinson Singleton United States	35	987 0.7×	86 0.1×	2.1k 2.8×	26 0.0×	1.8k 3.4×	56	4.2k

Countries citing papers authored by Anne L. Carrington

Since Specialization

Citations

This map shows the geographic impact of Anne L. Carrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne L. Carrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne L. Carrington more than expected).

Fields of papers citing papers by Anne L. Carrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne L. Carrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne L. Carrington. The network helps show where Anne L. Carrington may publish in the future.

Co-authorship network of co-authors of Anne L. Carrington

This figure shows the co-authorship network connecting the top 25 collaborators of Anne L. Carrington. A scholar is included among the top collaborators of Anne L. Carrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne L. Carrington. Anne L. Carrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munkonda, Mercedes N., Julie Martin, Paul Poirier, et al.. (2012). Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women. Nutrition and Diabetes. 2(8). e41–e41. 12 indexed citations

Philippidis, George & Anne L. Carrington. (2005). European Enlargement and Single Market Accession: A Mistreated Issue. Journal of Economic Integration. 20(3). 543–566. 7 indexed citations

Schie, Carine H.M. van, Cristiana Vermigli, Anne L. Carrington, & Andrew J.M. Boulton. (2004). Muscle Weakness and Foot Deformities in Diabetes. Diabetes Care. 27(7). 1668–1673. 80 indexed citations

Zandt, M.C. Van, E. Sibley, Brenda R. Flam, et al.. (2004). Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications. Bioorganic & Medicinal Chemistry. 12(21). 5661–5675. 44 indexed citations

Abbott, Caroline A., Anne L. Carrington, Sarah C. Bath, et al.. (2002). The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort. Diabetic Medicine. 19(5). 377–384. 752 indexed citations breakdown →

Dickinson, Peter J., Anne L. Carrington, Gary Frost, & Andrew J.M. Boulton. (2002). Neurovascular disease, antioxidants and glycation in diabetes. Diabetes/Metabolism Research and Reviews. 18(4). 260–272. 55 indexed citations

Carrington, Anne L., Caroline A. Abbott, John R. Griffiths, et al.. (2001). A Foot Care Program for Diabetic Unilateral Lower-Limb Amputees. Diabetes Care. 24(2). 216–221. 42 indexed citations

Walker, David, Anne L. Carrington, Diane R. Sawicki, et al.. (1999). Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. Journal of Anatomy. 195(3). 419–427. 44 indexed citations

Tomlinson, David R., et al.. (1998). Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase. Diabetic Medicine. 15(7). 579–585. 10 indexed citations

10.

Malik, Rayaz A., Caroline A. Abbott, Anne L. Carrington, et al.. (1998). Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. The Lancet. 352(9145). 1978–1981. 208 indexed citations

11.

Sramek, John J., Marilyn Gaston, Stanford S. Jhee, et al.. (1996). Establishing the Maximum Tolerated Dose of Lesopitron in Patients With Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 16(6). 454–458. 8 indexed citations

12.

Carrington, Anne L., et al.. (1996). Psychological status of diabetic people with or without lower limb disability. Diabetes Research and Clinical Practice. 32(1-2). 19–25. 154 indexed citations

13.

Stevens, Elizabeth, Anne L. Carrington, & David R. Tomlinson. (1994). Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia. 37(1). 43–48. 65 indexed citations

14.

Stevens, Elizabeth, et al.. (1993). Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia. 36(5). 397–401. 39 indexed citations

15.

Tomlinson, David R., et al.. (1993). Limitations of the Polyol Hypothesis in the Pathobiology of Experimental Diabetic Neuropathy. Diabetic Medicine. 10(S2). 27S–30S. 6 indexed citations

16.

Stevens, Elizabeth, Anne L. Carrington, & David R. Tomlinson. (1993). Prostacyclin release in experimental diabetes: Effects of evening primrose oil. Prostaglandins Leukotrienes and Essential Fatty Acids. 49(3). 699–706. 31 indexed citations

17.

Carrington, Anne L., et al.. (1993). Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. European Journal of Pharmacology. 237(2-3). 257–263. 49 indexed citations

18.

Tomlinson, David R., Gary B. Willars, & Anne L. Carrington. (1992). Aldose reductase inhibitors and diabetic complications. Pharmacology & Therapeutics. 54(2). 151–194. 90 indexed citations

19.

Calcutt, Nigel A., et al.. (1991). Resistance to hypoxic conduction block in sciatic nerves of rats with streptozotocin-induced diabetes mellitus. Journal of the Neurological Sciences. 103(1). 116–123. 15 indexed citations

20.

Price, David E., et al.. (1987). The relationship between peripheral nerve resistance to ischaemia and diabetic control.. Journal of Neurology Neurosurgery & Psychiatry. 50(12). 1671–1673. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact